JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY, cilt.27, sa.5, ss.531-539, 2014 (SCI-Expanded)
Background: Implementation of reliable noninvasive testing for screening cardiac allograft vasculopathy (CAV) is of critical importance. The most widely used modality, dobutamine stress echocardiography (DSE), has moderate sensitivity and specificity. The aim of this study was to assess the potential role of serial coronary flow reserve (CFR) assessment together with DSE for predicting CAV.